Legal & General Group PLC Corcept Therapeutics Inc Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 271,917 shares of CORT stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
271,917
Previous 252,443 7.71%
Holding current value
$11.9 Million
Previous $6.36 Million 38.92%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$22.21 - $34.48 $432,517 - $671,463
19,474 Added 7.71%
271,917 $8.83 Million
Q1 2024

Jul 01, 2024
BUY
$21.1 - $27.46 $87,881 - $114,370
4,165 Added 1.68%
252,443 $6.36 Million
Q1 2024

May 14, 2024
SELL
$21.1 - $27.46 $67,203 - $87,460
-3,185 Reduced 1.27%
248,278 $6.25 Million
Q4 2023

Feb 15, 2024
BUY
$24.82 - $32.88 $81,310 - $107,714
3,276 Added 1.32%
251,463 $8.17 Million
Q3 2023

Nov 14, 2023
SELL
$21.97 - $33.8 $191,270 - $294,262
-8,706 Reduced 3.39%
248,187 $6.76 Million
Q2 2023

Aug 14, 2023
SELL
$21.44 - $25.15 $481,713 - $565,070
-22,468 Reduced 8.04%
256,893 $5.72 Million
Q1 2023

May 15, 2023
SELL
$19.2 - $24.47 $16,358 - $20,848
-852 Reduced 0.3%
279,361 $6.05 Million
Q4 2022

Feb 14, 2023
BUY
$19.95 - $29.96 $115,690 - $173,738
5,799 Added 2.11%
280,213 $5.69 Million
Q3 2022

Nov 14, 2022
SELL
$24.7 - $29.12 $34,283 - $40,418
-1,388 Reduced 0.5%
274,414 $7.04 Million
Q2 2022

Aug 22, 2022
SELL
$17.33 - $25.3 $40,569 - $59,227
-2,341 Reduced 0.84%
275,802 $6.56 Million
Q1 2022

May 16, 2022
SELL
$16.53 - $25.21 $14,364 - $21,907
-869 Reduced 0.31%
278,143 $6.26 Million
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $191,502 - $261,384
-11,199 Reduced 3.86%
279,012 $5.53 Million
Q3 2021

Nov 15, 2021
BUY
$19.68 - $22.53 $415,385 - $475,540
21,107 Added 7.84%
290,211 $5.71 Million
Q2 2021

Aug 12, 2021
SELL
$19.97 - $24.43 $1.44 Million - $1.76 Million
-72,015 Reduced 21.11%
269,104 $5.92 Million
Q1 2021

May 17, 2021
BUY
$23.49 - $30.56 $238,094 - $309,756
10,136 Added 3.06%
341,119 $8.12 Million
Q4 2020

Feb 12, 2021
BUY
$16.78 - $27.3 $115,043 - $187,168
6,856 Added 2.12%
330,983 $8.66 Million
Q3 2020

Nov 13, 2020
BUY
$12.46 - $19.98 $73,439 - $117,762
5,894 Added 1.85%
324,127 $5.64 Million
Q2 2020

Aug 14, 2020
BUY
$11.0 - $18.26 $239,756 - $397,994
21,796 Added 7.35%
318,233 $5.35 Million
Q1 2020

May 14, 2020
BUY
$10.11 - $14.04 $9,644 - $13,394
954 Added 0.32%
296,437 $3.53 Million
Q4 2019

Feb 13, 2020
BUY
$12.06 - $16.96 $237,135 - $333,484
19,663 Added 7.13%
295,483 $3.58 Million
Q3 2019

Nov 13, 2019
BUY
$10.41 - $14.66 $126,450 - $178,075
12,147 Added 4.61%
275,820 $3.9 Million
Q2 2019

Aug 14, 2019
BUY
$9.78 - $12.76 $1,936 - $2,526
198 Added 0.08%
263,673 $2.94 Million
Q1 2019

May 15, 2019
BUY
$10.03 - $15.71 $224,982 - $352,391
22,431 Added 9.31%
263,475 $3.09 Million
Q4 2018

Feb 15, 2019
SELL
$11.29 - $17.19 $26,542 - $40,413
-2,351 Reduced 0.97%
241,044 $3.19 Million
Q3 2018

Nov 20, 2018
BUY
$12.27 - $15.65 $429,535 - $547,859
35,007 Added 16.8%
243,395 $3.39 Million
Q2 2018

Aug 10, 2018
BUY
$15.3 - $19.69 $199,450 - $256,678
13,036 Added 6.67%
208,388 $3.28 Million
Q1 2018

May 17, 2018
BUY
$14.59 - $25.5 $328,727 - $574,540
22,531 Added 13.04%
195,352 $3.18 Million
Q4 2017

Feb 13, 2018
BUY
$15.77 - $20.72 $2.73 Million - $3.58 Million
172,821
172,821 $3.12 Million

Others Institutions Holding CORT

# of Institutions
311
Shares Held
88.3M
Call Options Held
1.07M
Put Options Held
973K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.71B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email